Allergan’s deal spree continues with $2.9B LifeCell buyout
Allergan isn’t letting the holidays get in the way of its deal spree. The company has snapped up LifeCell and its aesthetic and regenerative …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
